Poluben L, Nouri M, Liang J, et al. Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer. Cell reports. 2024;44(1):115089. doi:10.1016/j.celrep.2024.115089
Pallasaho S, Gondane A, Kutz J, et al. Compromised CDK12 activity causes dependency on the high activity of O-GlcNAc transferase. Glycobiology. 2024. doi:10.1093/glycob/cwae081
Guo F, McGee EE, Chiu YH, Giovannucci E, Mucci LA, Dickerman BA. Evaluating recommendation-based dietary and physical activity strategies for prostate cancer prevention: a target trial emulation in the Health Professionals Follow-up Study. American journal of epidemiology. 2024. doi:10.1093/aje/kwae184
Rumpf F, Plym A, Vaselkiv JB, et al. Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer. The Journal of urology. 2024:101097JU0000000000003927. doi:10.1097/JU.0000000000003927
Amini AE, Hunter AE, Almashad A, et al. Magnetic Resonance Imaging-based Prostate Cancer Screening in Carriers of Pathogenic Germline Mutations: Interim Results from the Initial Screening Round of the Prostate Cancer Genetic Risk Evaluation and Screening Study. European urology oncology. 2024. doi:10.1016/j.euo.2024.01.015
Kamran SC, Kerkmeijer LGW, Zamboglou C. Editorial: Advances in radiotherapy for prostate cancer. Frontiers in oncology. 2022;12:1122652. doi:10.3389/fonc.2022.1122652